Doctor profile · Federal record
Dr. HELEN NOBLE, M.D.
Internal Medicine Physician · CHESTERTOWN, MD
- NPI 1275537896
- 21 yrs on file
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
122 SPEER RD, STE 5
CHESTERTOWN, MD 216201033
(410) 778-0200
fax (410) 778-6647
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- July 8, 2007
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- Maryland #D0041587
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275537896. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,501
Distinct HCPCS
10
Medicare allowed
$108,807
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,560 | 18 | $23 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 357 | 146 | $92 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 129 | 76 | $131 | |
36415 |
Insertion of needle into vein for collection of blood sample | 121 | 85 | $8 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 65 | 65 | $132 | |
G0008 |
Administration of influenza virus vaccine | 63 | 61 | $31 | |
90682 |
Influenza vaccine, quadrivalent derived from recombinant dna | 62 | 60 | $72 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 36 | 23 | $48 | |
99308 |
Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | 30 | 23 | $76 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 25 | 18 | $75 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 169. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$83
Transactions
5
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 2 | $33.39 | |
| Otsuka America Pharmaceutical, Inc. | 1 | $18.08 | |
| GlaxoSmithKline, LLC. | 1 | $15.91 | |
| Amgen Inc. | 1 | $15.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,521
Patients
377
Total drug cost
$170,858
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Losartan Potassium | Generic | 214 | 45 | $3,693 |
| Rosuvastatin Calcium | Generic | 148 | 35 | $4,788 |
| Levothyroxine Sodium | Generic | 141 | 38 | $1,890 |
| Atorvastatin Calcium | Generic | 120 | 35 | $2,834 |
| Hydrochlorothiazide | Generic | 110 | 32 | $1,019 |
| Eliquis (Apixaban) | Brand | 103 | 18 | $98,673 |
| Furosemide | Generic | 102 | 31 | $712 |
| Metoprolol Succinate | Generic | 94 | 27 | $3,380 |
| Amlodipine Besylate | Generic | 92 | 23 | $1,277 |
| Metformin Hcl | Generic | 76 | 20 | $1,369 |